Evidence map›Paper›PMID 31773494›Full record

ArticleInternational journal of hematology2020

Correction to: Analysis of glutathione S-transferase and cytochrome P450 gene polymorphism in recipients of dose-adjusted busulfan-cyclophosphamide conditioning.

Seitaro Terakura, Makoto Onizuka, Mariko Fukumoto, Yachiyo Kuwatsuka, Akio Kohno, Yukiyasu Ozawa, Koichi Miyamura, Yuichiro Inagaki, Masashi Sawa, Yoshiko Atsuta and 5 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Seitaro TerakuraDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan. tseit@med.nagoya-u.ac.jp.ORCID http://orcid.org/0000-0002-1194-8046
Makoto OnizukaDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Mariko FukumotoDivision of Clinical Toxicology, Research and Education Center for Clinical Pharmacy, School of Pharmaceutical Sciences, Kitasato University, Tokyo, Japan.
Yachiyo KuwatsukaDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Akio KohnoDepartment of Hematology and Oncology, JA Aichi Konan Kosei Hospital, Konan, Japan.
Yukiyasu OzawaDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Koichi MiyamuraDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Yuichiro InagakiDepartment of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
Masashi SawaDepartment of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan.
Yoshiko AtsutaDepartment of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Ritsuro SuzukiDepartment of HSCT Data Management/Biostatistics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Tomoki NaoeDepartment of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Aichi, Japan.
Yoshihisa MorishitaDepartment of Hematology and Oncology, JA Aichi Konan Kosei Hospital, Konan, Japan.
Makoto MurataDepartment of Hematology and Oncology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Aichi, Japan.
Nagoya Blood and Marrow Transplantation Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original article of Terakura et al., the COI disclosure were missing.

Identifiers

PMID31773494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.